CDMO
- Business Wire
AMRI Becomes Curia
New Brand Reinforces Commitment to Ongoing Expansion of Expertise, Capabilities and Contributions to Health Care ALBANY, N.Y.–(BUSINESS WIRE)–#AMRI–Albany Molecular Research,…
Read More » - World
Philip Morris International Announces Agreement to Acquire Fertin Pharma
Lausanne, Switzerland: Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has entered into an agreement to acquire Fertin…
Read More » - Business
Aragen (Formerly GVK BIO) To Partner With Global Biopharma With a Renewed Brand Promise
Hyderabad, Telangana, India: Aragen Life Sciences (Aragen), formerly known as GVK Biosciences and a leading contract research, development and manufacturing…
Read More » - Business
Goldman Sachs Invests in Aragen Life Sciences
Hyderabad, India: Aragen Life Sciences (“Aragen”), formerly known as GVK Biosciences and a leading contract research organization (CRO), announced today…
Read More » - World
Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
Seoul, South Korea: Veeva Systems (NYSE: VEEV) today announced that Samsung Biologics, an award-winning global contract development and manufacturing organization (CDMO),…
Read More » - India
CCI approves proposed combination involving acquisition of 20% of the issued and paid-up equity share capital of Piramal Pharma Limited (Pharma Co.) by CA Clover Intermediate II Investments (Curie)
The Competition Commission of India (CCI) approves proposed combination involving acquisition of 20% of the issued and paid-up equity share…
Read More »